For this reason and because our own previous whole transcriptome studies of healthy donor blood samples indicated the absence of BPIFA1 transcripts in healthy blood [49], we assumed that BPIFA1 would be an ideal marker for lung cancer CTCs. The gene discussed is BPIFA1; the disease is lung carcinoma.